These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current developments of immunotherapy in the clinic. Antonia S; Mulé JJ; Weber JS Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403 [TBL] [Abstract][Full Text] [Related]
4. The treatment of melanoma with an emphasis on immunotherapeutic strategies. Jack A; Boyes C; Aydin N; Alam K; Wallack M Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006 [TBL] [Abstract][Full Text] [Related]
5. Self-recognition and tumor response to immunotherapy. Ernstoff MS J Clin Oncol; 2005 Sep; 23(25):5875-7. PubMed ID: 16087939 [No Abstract] [Full Text] [Related]
6. Vaccine therapy for melanoma: current status and future directions. Terando AM; Faries MB; Morton DL Vaccine; 2007 Sep; 25 Suppl 2():B4-16. PubMed ID: 17646038 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of melanoma: the good news, the bad ones and what to do next. Marincola FM; Ferrone S Semin Cancer Biol; 2003 Dec; 13(6):387-9. PubMed ID: 15001156 [No Abstract] [Full Text] [Related]
9. [Immunotherapy for melanoma: how can tolerance be overcome?]. Robert C Ann Dermatol Venereol; 2001; 128(6-7):709-13. PubMed ID: 11460031 [No Abstract] [Full Text] [Related]
10. [Active specific immunotherapy of malignant melanoma]. Lotem M; Shiloni E; Ingber A; Peretz T Harefuah; 1997 Aug; 133(3-4):122-6. PubMed ID: 9332080 [No Abstract] [Full Text] [Related]
12. Cancer vaccines and immunotherapies: emerging perspectives. Henderson RA; Mossman S; Nairn N; Cheever MA Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628 [TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches]. Enk AH; Becker JC; Schuler G J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for the management of advanced melanoma: the next steps. Zikich D; Schachter J; Besser MJ Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145 [TBL] [Abstract][Full Text] [Related]
15. [General principles and first clinical trials of therapeutic vaccines against cancer]. Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunotherapy in the treatment of melanoma. Faries MB Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223 [TBL] [Abstract][Full Text] [Related]
17. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders? Lejeune FJ Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085 [No Abstract] [Full Text] [Related]
18. Immunotherapy for cutaneous malignancy. Ibrahim SF; Sambandan D; Ratner D Dermatol Surg; 2011 Oct; 37(10):1377-93. PubMed ID: 21806705 [TBL] [Abstract][Full Text] [Related]